Literature DB >> 30089729

Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans.

Thomas Morville1, Ronni E Sahl1,2, Samuel Aj Trammell2, Jens S Svenningsen2, Matthew P Gillum2, Jørn W Helge1, Christoffer Clemmensen2.   

Abstract

BACKGROUND: Exercise has profound pleiotropic health benefits, yet the underlying mechanisms remain incompletely understood. Endocrine FGF21, bile acids (BAs), and BA-induced FGF19 have emerged as metabolic signaling molecules. Here, we investigated if dissimilar modes of exercise, resistance exercise (RE) and endurance exercise (EE), regulate plasma BAs, FGF19, and FGF21 in humans.
METHODS: Ten healthy, moderately trained males were enrolled in a randomized crossover study of 1 hour of bicycling at 70% of VO2peak (EE) and 1 hour of high-volume RE. Hormones and metabolites were measured in venous blood and sampled before and after exercise and at 15, 30, 60, 90, 120, and 180 minutes after exercise.
RESULTS: We observed exercise mode-specific changes in plasma concentrations of FGF19 and FGF21. Whereas FGF19 decreased following RE (P < 0.001), FGF21 increased in response to EE (P < 0.001). Total plasma BAs decreased exclusively following RE (P < 0.05), but the composition of BAs changed in response to both types of exercise. Notably, circulating levels of the potent TGR5 receptor agonist, lithocholic acid, increased with both types of exercise (P < 0.001).
CONCLUSION: This study reveals divergent effects of EE and RE on circulating concentrations of the BA species, FGF19, and FGF21. We identify temporal relationships between decreased BA and FGF19 following RE and a sharp disparity in FGF21 concentrations, with EE eliciting a clear increase parallel to that of glucagon. FUNDING: The Novo Nordisk Foundation (NNF17OC0026114) and the Lundbeck Foundation (R238-2016-2859).

Entities:  

Keywords:  Endocrinology; Glucose metabolism; Metabolism; Skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 30089729      PMCID: PMC6129127          DOI: 10.1172/jci.insight.122737

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  25 in total

1.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Authors:  T Lundåsen; C Gälman; B Angelin; M Rudling
Journal:  J Intern Med       Date:  2006-12       Impact factor: 8.989

2.  Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.

Authors:  Jakob Schiøler Hansen; Bente Klarlund Pedersen; Guowang Xu; Rainer Lehmann; Cora Weigert; Peter Plomgaard
Journal:  J Clin Endocrinol Metab       Date:  2016-05-10       Impact factor: 5.958

3.  The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity.

Authors:  Evie P M Broeders; Emmani B M Nascimento; Bas Havekes; Boudewijn Brans; Kay H M Roumans; Anne Tailleux; Gert Schaart; Mostafa Kouach; Julie Charton; Benoit Deprez; Nicole D Bouvy; Felix Mottaghy; Bart Staels; Wouter D van Marken Lichtenbelt; Patrick Schrauwen
Journal:  Cell Metab       Date:  2015-07-30       Impact factor: 27.287

4.  FGF19 action in the brain induces insulin-independent glucose lowering.

Authors:  Gregory J Morton; Miles E Matsen; Deanna P Bracy; Thomas H Meek; Hong T Nguyen; Darko Stefanovski; Richard N Bergman; David H Wasserman; Michael W Schwartz
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  TGR5-mediated bile acid sensing controls glucose homeostasis.

Authors:  Charles Thomas; Antimo Gioiello; Lilia Noriega; Axelle Strehle; Julien Oury; Giovanni Rizzo; Antonio Macchiarulo; Hiroyasu Yamamoto; Chikage Mataki; Mark Pruzanski; Roberto Pellicciari; Johan Auwerx; Kristina Schoonjans
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

Review 6.  Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.

Authors:  Bryn M Owen; David J Mangelsdorf; Steven A Kliewer
Journal:  Trends Endocrinol Metab       Date:  2014-12-01       Impact factor: 12.015

7.  TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease.

Authors:  Kazuaki Yoneno; Tadakazu Hisamatsu; Katsuyoshi Shimamura; Nobuhiko Kamada; Riko Ichikawa; Mina T Kitazume; Maiko Mori; Michihide Uo; Yuka Namikawa; Katsuyoshi Matsuoka; Toshiro Sato; Kazutaka Koganei; Akira Sugita; Takanori Kanai; Toshifumi Hibi
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

8.  Acute exercise induces FGF21 expression in mice and in healthy humans.

Authors:  Kook Hwan Kim; Seong Hun Kim; Young-Ki Min; Hun-Mo Yang; Jeong-Beom Lee; Myung-Shik Lee
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  Fibroblast growth factor 21 mediates specific glucagon actions.

Authors:  Kirk M Habegger; Kerstin Stemmer; Christine Cheng; Timo D Müller; Kristy M Heppner; Nickki Ottaway; Jenna Holland; Jazzminn L Hembree; David Smiley; Vasily Gelfanov; Radha Krishna; Ayman M Arafat; Anish Konkar; Sara Belli; Martin Kapps; Stephen C Woods; Susanna M Hofmann; David D'Alessio; Paul T Pfluger; Diego Perez-Tilve; Randy J Seeley; Morichika Konishi; Nobuyujki Itoh; Alexei Kharitonenkov; Joachim Spranger; Richard D DiMarchi; Matthias H Tschöp
Journal:  Diabetes       Date:  2013-01-10       Impact factor: 9.461

10.  Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation.

Authors:  Yuko Tanimura; Wataru Aoi; Yoshikazu Takanami; Yukari Kawai; Katsura Mizushima; Yuji Naito; Toshikazu Yoshikawa
Journal:  Physiol Rep       Date:  2016-06
View more
  28 in total

1.  An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides.

Authors:  Trisha J Grevengoed; Samuel Aj Trammell; Jens S Svenningsen; Mikhail V Makarov; Thomas Svava Nielsen; Jens Christian Brings Jacobsen; Jonas T Treebak; Philip C Calder; Marie E Migaud; Benjamin F Cravatt; Matthew P Gillum
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

2.  Divergence in aerobic capacity impacts bile acid metabolism in young women.

Authors:  Adrianna Maurer; Jaimie L Ward; Kelsey Dean; Sandra A Billinger; Haixia Lin; Kelly E Mercer; Sean H Adams; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2020-08-27

3.  Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.

Authors:  Alana E O'Mara; James W Johnson; Joyce D Linderman; Robert J Brychta; Suzanne McGehee; Laura A Fletcher; Yael A Fink; Devika Kapuria; Thomas M Cassimatis; Nathan Kelsey; Cheryl Cero; Zahraa Abdul Sater; Francesca Piccinini; Alison S Baskin; Brooks P Leitner; Hongyi Cai; Corina M Millo; William Dieckmann; Mary Walter; Norman B Javitt; Yaron Rotman; Peter J Walter; Marilyn Ader; Richard N Bergman; Peter Herscovitch; Kong Y Chen; Aaron M Cypess
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts.

Authors:  Tracey G Simon; Mi Na Kim; Xiao Luo; Wanshui Yang; Yanan Ma; Dawn Q Chong; Charles S Fuchs; Jeffrey A Meyerhardt; Kathleen E Corey; Raymond T Chung; Meir Stampfer; Xuehong Zhang; Edward L Giovannucci; Andrew T Chan
Journal:  J Hepatol       Date:  2020-01-15       Impact factor: 25.083

Review 5.  Metabolic Messengers: bile acids.

Authors:  Alessia Perino; Kristina Schoonjans
Journal:  Nat Metab       Date:  2022-03-25

6.  Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2.

Authors:  Stephanie Holm; Anna S Husted; Louise J Skov; Thomas H Morville; Christoffer A Hagemann; Tina Jorsal; Morten Dall; Alexander Jakobsen; Anders B Klein; Jonas T Treebak; Filip K Knop; Thue W Schwartz; Christoffer Clemmensen; Birgitte Holst
Journal:  Endocrinology       Date:  2022-06-01       Impact factor: 5.051

7.  Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool.

Authors:  Ambrin Farizah Babu; Susanne Csader; Ville Männistö; Milla-Maria Tauriainen; Heikki Pentikäinen; Kai Savonen; Anton Klåvus; Ville Koistinen; Kati Hanhineva; Ursula Schwab
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

8.  Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.

Authors:  Samuel A J Trammell; Jens S Svenningsen; Jens J Holst; Matthew P Gillum; Rune E Kuhre
Journal:  Molecules       Date:  2020-05-20       Impact factor: 4.411

9.  Metabolic Architecture of Acute Exercise Response in Middle-Aged Adults in the Community.

Authors:  Matthew Nayor; Ravi V Shah; Patricia E Miller; Jasmine B Blodgett; Melissa Tanguay; Alexander R Pico; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Amy Deik; Kerry A Pierce; Kevin Bullock; Lucas Dailey; Raghava S Velagaleti; Stephanie A Moore; Jennifer E Ho; Aaron L Baggish; Clary B Clish; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis
Journal:  Circulation       Date:  2020-09-15       Impact factor: 29.690

Review 10.  Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes.

Authors:  Yingjie Wu; An Zhou; Li Tang; Yuanyuan Lei; Bo Tang; Linjing Zhang
Journal:  J Diabetes Res       Date:  2020-07-17       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.